PHAVERSO
ActiveFinancials · financial year 2025, abbreviated format
2025 annual accounts filed 28 days after the deadline Filed on 28 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00488301.
Annual accounts 2025 filed on 28-08-2026 at the NBB all 20 filings
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result for 2025 is 3% lower than in 2024.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Average staff per financial year, in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Retail trade (NACE 47). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio, return on assets (ROA) and staff (FTE).
Comparable companies
These companies have the same main activity as PHAVERSO: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €2.3m and €3.7m, founded between 1995 and 2010.
| Company | Founded | Total assets | Equity | Gross margin | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| PHAVERSO Moorslede | 2005 | €3.3m | €1.8m | €1.0m | €0.3m | 5.4 | 2025 |
| Apotheek Meense & Delta Roeselare | 1995 | €3.3m | €2.3m | €0.9m | €0.4m | 4.7 | 2025 |
| Vandewalle-Verrue Vleteren | 2010 | €2.3m | €0.8m | €0.9m | €0.5m | 5.5 | 2026 |
| DEDEYNE BRUNO Aalter | 2002 | €3.2m | €1.5m | €0.8m | €0.4m | 4.5 | 2025 |
| Pharmacie de Warsage Dalhem | 2008 | €3.4m | €1.1m | €0.9m | €0.1m | 7 | 2025 |
| Remopharma Sint-Gillis-Waas | 2008 | €3.7m | €2.2m | €1.1m | €0.2m | 7 | 2025 |
| JECO FARMA Brakel | 2007 | €3.4m | €2.3m | €0.9m | €0.4m | 3.9 | 2025 |
They were chosen from the 3,936 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | - | €0.006m | - | - | - |
| Remuneration, social security and pensions62 | - | - | - | €0.2m | €0.2m | €0.3m | €0.4m | €0.4m | ▲ 0.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.08m | €0.08m | €0.05m | €0.05m | €0.06m | €0.06m | €0.07m | €0.05m | ▼ 35.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | - | €379 | €0.007m | €0.01m | €0.02m | ▲ 55.6% |
| Other operating charges640/8 | - | - | - | €0.005m | €0.004m | €0.004m | €0.006m | €0.006m | ▼ 5.3% |
| Gross operating margin9900 | €0.5m | €0.6m | €0.7m | €0.6m | €0.7m | €0.9m | €1.1m | €1.0m | ▼ 3.1% |
| Operating profit (loss)9901 | €0.2m | €0.3m | €0.4m | €0.3m | €0.4m | €0.5m | €0.6m | €0.5m | ▼ 2.6% |
| Financial income75/76B | - | - | - | €0.007m | €0.005m | €0.01m | €0.2m | €0.007m | ▼ 95.5% |
| Recurring financial income75 | €0.003m | €0.005m | €0.1m | €0.007m | €0.005m | €0.01m | €0.2m | €0.007m | ▼ 95.5% |
| Financial charges65/66B | - | - | - | €0.06m | €0.06m | €0.07m | €0.08m | €0.08m | ▼ 2.1% |
| Recurring financial charges65 | €0.04m | €0.08m | €0.06m | €0.06m | €0.06m | €0.07m | €0.08m | €0.08m | ▼ 2.1% |
| Profit (loss) for the period before taxes9903 | €0.2m | €0.2m | €0.4m | €0.3m | €0.3m | €0.4m | €0.6m | €0.5m | ▼ 24.7% |
| Income taxes67/77 | €0.07m | €0.07m | €0.1m | €0.09m | €0.1m | €0.1m | €0.1m | €0.1m | ▲ 1.7% |
| Profit (loss) for the period9904 | €0.1m | €0.2m | €0.3m | €0.2m | €0.2m | €0.3m | €0.5m | €0.3m | ▼ 32.7% |
| Profit (loss) for the period to be appropriated9905 | €0.1m | €0.2m | €0.3m | €0.2m | €0.2m | €0.3m | €0.5m | €0.3m | ▼ 32.7% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €2.8m | €2.8m | €2.7m | €2.7m | €2.9m | €3.2m | €3.1m | €3.3m | ▲ 6.9% |
| Fixed assets21/28 | €2.0m | €2.0m | €2.0m | €2.0m | €2.0m | €2.0m | €2.0m | €2.1m | ▲ 9.2% |
| Intangible fixed assets21 | €0.02m | €0.01m | - | - | €0.002m | €0.001m | €0.009m | €0.005m | ▼ 41.1% |
| Tangible fixed assets22/27 | €0.4m | €0.4m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.5m | ▲ 65.1% |
| Land and buildings22 | - | - | - | €0.2m | €0.2m | €0.2m | €0.2m | €0.4m | ▲ 122% |
| Plant, machinery and equipment23 | - | - | - | €0.02m | €0.03m | €0.02m | €0.02m | €0.02m | ▼ 6.5% |
| Furniture and vehicles24 | - | - | - | €0.006m | €0.02m | €0.09m | €0.07m | €0.05m | ▼ 30.0% |
| Other tangible fixed assets26 | - | - | - | €0.08m | €0.06m | €0.05m | €0.02m | €0.01m | ▼ 26.5% |
| Financial fixed assets28 | €1.6m | €1.7m | €1.7m | €1.7m | €1.7m | €1.7m | €1.7m | €1.7m | = |
| Current assets29/58 | €0.7m | €0.7m | €0.7m | €0.8m | €0.9m | €1.2m | €1.1m | €1.1m | ▲ 2.8% |
| Stocks and contracts in progress3 | €0.2m | €0.2m | €0.3m | €0.3m | €0.3m | €0.4m | €0.5m | €0.4m | ▼ 6.6% |
| Stocks30/36 | - | - | - | €0.3m | €0.3m | €0.4m | €0.5m | €0.4m | ▼ 6.6% |
| Amounts receivable within one year40/41 | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | €0.3m | €0.3m | €0.3m | ▲ 3.4% |
| Trade receivables40 | - | - | - | €0.2m | €0.2m | €0.2m | €0.3m | €0.3m | ▲ 13.8% |
| Other amounts receivable41 | - | - | - | €0.009m | €0.01m | €0.01m | €0.04m | €0.01m | ▼ 68.5% |
| Current investments50/53 | - | - | - | - | - | €0.3m | - | €0.1m | - |
| Cash at bank and in hand54/58 | €0.3m | €0.3m | €0.2m | €0.3m | €0.4m | €0.2m | €0.3m | €0.2m | ▼ 16.5% |
| Deferred charges and accrued income490/1 | - | - | - | €0.001m | €0.002m | €0.007m | €0.001m | €0.002m | ▲ 25.7% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €2.8m | €2.8m | €2.7m | €2.7m | €2.9m | €3.2m | €3.1m | €3.3m | ▲ 6.9% |
| Equity10/15 | €0.6m | €0.7m | €1.0m | €1.2m | €1.3m | €1.3m | €1.6m | €1.8m | ▲ 14.1% |
| Contributions10/11 | €0.02m | €0.02m | - | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | = |
| Revaluation surpluses12 | - | - | - | - | - | - | - | €0.2m | - |
| Reserves13 | €0.6m | €0.7m | €1.0m | €1.2m | €1.3m | €1.2m | €1.6m | €1.6m | = |
| Non-distributable reserves130/1 | - | - | - | €0.002m | - | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.002m | - | - | - | - | - |
| Distributable reserves133 | - | - | - | €1.2m | €1.3m | €1.2m | €1.6m | €1.6m | = |
| Amounts payable17/49 | €2.2m | €2.0m | €1.7m | €1.6m | €1.5m | €1.9m | €1.5m | €1.5m | ▼ 0.6% |
| Amounts payable after more than one year17 | €1.8m | €1.5m | €1.3m | €1.2m | €1.1m | €1.0m | €0.8m | €0.7m | ▼ 16.5% |
| Financial debts170/4 | - | - | - | €1.2m | €1.1m | €1.0m | €0.8m | €0.7m | ▼ 16.5% |
| Amounts payable within one year42/48 | €0.4m | €0.6m | €0.3m | €0.3m | €0.5m | €0.9m | €0.6m | €0.8m | ▲ 22.5% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.1m | €0.1m | €0.2m | €0.1m | €0.1m | ▼ 14.4% |
| Financial debts43 | - | - | - | €0.02m | €0.05m | €0.02m | - | - | - |
| Credit institutions430/8 | - | - | - | €0.02m | €0.05m | €0.02m | - | - | - |
| Trade debts44 | €0.1m | €0.1m | €0.08m | €0.1m | €0.1m | €0.1m | €0.2m | €0.2m | ▼ 16.4% |
| Suppliers440/4 | - | - | - | €0.1m | €0.1m | €0.1m | €0.2m | €0.2m | ▼ 16.4% |
| Taxes, remuneration and social security45 | - | - | - | €0.05m | €0.07m | €0.08m | €0.08m | €0.05m | ▼ 30.2% |
| Taxes450/3 | - | - | - | €0.02m | €0.03m | €0.03m | €0.01m | €0.02m | ▲ 30.2% |
| Remuneration and social security454/9 | - | - | - | €0.03m | €0.04m | €0.05m | €0.06m | €0.04m | ▼ 42.1% |
| Other amounts payable47/48 | - | - | - | €0.04m | €0.1m | €0.6m | €0.2m | €0.4m | ▲ 102% |
| Accrued charges and deferred income492/3 | - | - | - | €0.002m | €0.001m | €0.002m | €0.02m | €0.004m | ▼ 77.3% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €134,322 | €163,889 | €326,156 | €194,430 | €239,815 | €299,266 | €487,019 | €327,651 | ▼ 32.7% |
| + Depreciation and write-downs630 | €77,568 | €75,859 | €46,240 | €49,914 | €58,028 | €57,534 | €71,093 | €45,928 | ▼ 35.4% |
| Operating cash flow (approximation) | €211,890 | €239,748 | €372,396 | €244,344 | €297,843 | €356,801 | €558,112 | €373,580 | ▼ 33.1% |
| Investment in fixed assets (approximation) | - | -€70,807 | -€18,227 | -€13,783 | -€55,297 | -€102,274 | -€18,222 | -€227,239 | ▼ 1,147% |
| Change in cash | - | -€6,531 | -€73,030 | €61,446 | €140,932 | -€192,224 | €86,325 | -€48,665 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Latest 10 of 20 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | abbreviated format | 28-08-2026 | 2026-00488301 | NBB |
| 31-12-2024 | abbreviated format | 28-07-2025 | 2025-00334671 | |
| 31-12-2023 | abbreviated format | 28-08-2024 | 2024-00398075 | |
| 31-12-2022 | abbreviated format | 20-07-2023 | 2023-00256080 | |
| 31-12-2021 | abbreviated format | 06-07-2022 | 2022-20150197 | |
| 31-12-2020 | abbreviated format | 16-08-2021 | 2021-49100397 | |
| 31-12-2019 | abbreviated format | 31-07-2020 | 2020-37400310 | |
| 31-12-2018 | abbreviated format | 26-08-2019 | 2019-51400553 | |
| 31-12-2017 | abbreviated format | 29-06-2018 | 2018-27000216 | |
| 31-12-2016 | abbreviated format | 03-08-2017 | 2017-41300050 |